Akums gets DCGI nod for triple combination diabetes medication

Akums Drugs and Pharmaceuticals has received approval from the Drug Controller General of India (DCGI) for a triple combination diabetes medication. The drug combines Sitagliptin 100, Pioglitazone 15, and Metformin 1000/500 to provide better treatment without the need for multiple drugs.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news